Open Orphan - £8.1m Asthma Human Challenge Study Contract Win
ORPH
Tue, 24 Aug 2021, 07:15 BST
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com
Cathal Friel, Executive Chairman of Open Orphan, provides an update on the £8.1m Asthma Human Challenge Study Contract Win.
